Despite growing interest in potential off-label uses of Ozempic, there is currently no clinical evidence or licensed indication supporting its use for fibromyalgia
GLP-1 users are particularly vulnerable during phases of high nausea, low appetite, or dietary fatigue
In major clinical studies, semaglutide has helped many participants lose approximately 15% of their body weight over about two years
This usually involves a period of documented diet and exercise changes, sometimes supervised by a healthcare professional
For those with PCOS considering GLP-1 medications, the message is straightforward: these treatments hold promise, but they work best as part of a carefully managed, personalized care plan
Key Takeaways GLP-1 medications slow gastric emptying, which increases stomach pressure and forces acid back into the esophagus, causing heartburn